This is the first episode of a two-part educational series to raise awareness of epidermolysis bullosa (EB) and the latest FDA-approved treatment options for this disease. Our host, Dr. Joyce Teng, MD, PhD, Professor of Dermatology and Pediatrics at Stanford University School of Medicine in Stanford, CA, is joined by Dr. Michael Lavery, a Pediatric Dermatologist and Clinical Assistant Professor at the University of Florida in Gainesville, FL, as they discuss the following topics:

• Epidemiology and prevalence of EB

• Burden of disease and impact on patients' quality of life

• Gaps and challenges for patients with EB

• Assessing the current knowledge of clinicians and gaps in care recommendations